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Introduction
We are the biggest center for Histopathology in 
Pakistan, a country of over 180 million people, and 
receive cases from all over the country. Last year, we 
reported over 57,000 surgical pathology and over 18,000 
cytology specimens. We are a major referral center for 
difficult and challenging cases from all over the country 
and malignant tumors constitute a major chunk of our 
practice. Since we receive cases from all over Pakistan, 
frequencies of various malignant tumors in our practice 
are a fair indication of their frequency in Pakistan. Even 
today, there is no ‘cancer registry’ in Pakistan and there 
is no definite data regarding the incidence of various 
cancers. This state of affairs is very depressing since 
cancer takes a heavy toll of human life in this extremely 
populous country and incurs a huge cost in terms of 
morbidity and mortality. The majority of the people are 
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 Context: There are no recent authoritative data about incidence and prevalence of various types of cancers in 
Pakistan. Aim: To determine the frequency of malignant tumors seen in our practice and provide a foundation 
for building a comprehensive cancer care strategy. Materials and Methods: 10,000 successive cases of solid 
malignant tumors reported in 2014 were included. All cases had formalin fixed, paraffin embedded specimens 
available and diagnosis was based on histological examination of H&E stained slides plus ancillary studies at the 
Section of Histopathology, Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, 
Karachi. The latest WHO classifications were used along with the latest CAP protocols for reporting and the most 
updated TNM staging. Results: There were 9,492 (94.9%) primary tumors while 508 (5.1%) were metastatic. 
Some 5,153 (51.5%) were diagnosed in females and 4,847 (48.5%) in males.  The commonest malignant tumors 
in females were breast (32%), esophagus (7%), lymphomas (6.8%), oral cavity (6.7%) and ovary (4.8%), while 
in males they were oral cavity (13.9%), lymphomas (12.8%), colorectum (7.9%), stomach (6.9%) and esophagus 
(6.6%). Malignant tumors were most common in the 5th, 6th and 7th decades. About 8% were seen under 20 
years of age. Conclusions: Oral cavity and gastrointestinal cancers continue to be extremely common in both 
genders. Breast and esophageal cancers are prevalent in females. Lung and prostate cancer are less common 
than in the west. Ovarian cancer was very common but cervix cancer was less so. 
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poor, and have little access to even basic necessities of 
life. Not only are accurate figures regarding the incidence 
and prevalence of cancers unknown, the diagnosis and 
management of malignant tumors is extremely suboptimal 
(in terms of facilities, qualified physicians, therapeutic 
options etc.). The majority of patients cannot afford the 
cost of treatment. Cancer patients often die painful and 
miserable deaths. Little to no facilities are available in 
remote areas and people need to travel to larger cities in 
order to get treatment which is very expensive. Although 
the government and private sector have taken a number 
of initiatives to improve cancer care in the country, the 
overall situation remains bleak. 
An important step in achieving better cancer care 
is to determine the incidence of various cancers in the 
country. A pathology department cannot accurately 
determine cancer incidence. However, being the busiest 
histopathology department in the country receiving cases 
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from all over Pakistan, we can provide a fair assessment 
of the frequency of various cancers in Pakistan.
The aim of this study was to determine the frequency 
of various cancers in Pakistan based on our practice. This 
data will hopefully provide a foundation which can help 
in building an accurate cancer registry and developing a 
comprehensive cancer care strategy.
Materials and Methods
A total of 10,000 successive cases of malignant 
tumors reported in the Section of Histopathology, AKUH 
in the year 2014 were included in the study. Only solid 
tumors were included, leukemias were excluded. All 
cases included were formalin fixed, paraffin embedded 
specimens. Only tumors fulfilling well defined criteria 
for malignancy were included. Borderline tumors such 
as borderline ovarian neoplasms or borderline phylloides 
tumor of breast were not included. Giant cell tumor of 
the bone, borderline histiocytomas (dermatofibrosarcoma 
protuberans), and locally aggressive conditions such as 
fibromatosis were not included. Gastrointestinal (including 
pancreatobiliary) neuroendocrine tumors (NETs) were 
included. Low grade appendiceal mucinous neoplasms 
(LAMNs) and low grade pseudomyxoma peritonei were 
excluded. All grade II and higher Central Nervous System 
(CNS) neoplasms were included. However, grade I CNS 
tumors such as pilocytic astrocytoma, grade I meningioma, 
myxopapillary ependymoma etc were not included. In all 
cases, diagnosis was based on microscopic examination 
Table 1. Malignant Tumors in Males and Females Combined (n=10,000)
S. 
No 
#
Organ and tumor Type "Over all Total No.”
Percentage 
(%) 
Females 
Total 
No. 
(5153)
Percentage 
(%) 
Males Total 
No. (4847)
Percentage 
(%) 
1 Breast Cancer 1650 16.5% 1650 32.0% - -
2 Oral cavity Carcinoma* 1021 10.2% 345 6.7% 676 13.9%
3
Lymphoma 974 9.7% 352 6.8% 622 12.8%
   Non Hodgkin Lymphoma Nodal  (375)  (130)  (245)
   Non Hodgkin Lymphoma Extranodal  (358)  (126)  (232)
   Hodgkin Lymphoma  (241)  (96)  (145)
4 Esophageal Carcinoma  680 6.8%  362 7.0%  318 6.6%
5 Colorectal Carcinoma  595 5.9%  211 4.1%  384 7.9%
6 Skin Carcinoma  489 4.9%  201 3.9%  288 5.9%
7 Gastric Carcinoma  475 4.7%  139 2.7%  336 6.9%
8 Lung Carcinoma  380 3.8%  77 1.5%  303 6.3%
9 CNS Malignant Tumor**  356 3.6%  117 2.3%  239 4.9%
10 Urinary bladder Carcinoma  325 3.2%  80 1.5%  245 5.1%
11 Larynx and vocal cord carcinoma  270 2.7%  105 2.0%  165 3.4%
12 Ovarian Carcinoma  248 2.5%  248 4.8% - -
13 Prostate Carcinoma  237 2.4% - -  237 4.8%
14 Endometrial Carcinoma  187 4.8%  187 3.6% - -
15 Cervix Carcinoma  140 1.4%  140 2.7% - -
16 Thyroid Carcinoma  137 1.4%  91 1.8% 46 0.9%
17 Renal carcinoma  123 1.2%  43 0.8% 80 1.6%
18 Ewing Sarcoma  119 1.2%  56 1.1% 64 1.3%
19 Gall bladder carcinoma  104 1.04%  75 1.4% 29 0.6%
20 Testicular malignant Tumors  102 1.02% - - 102 2.1%
21 Ampullary, Periamapullary, pancreatic, Small intestine Carcinoma  102 1.02%  38 0.7% 64 1.3%
22 Salivary gland malignancies  88 0.9%  33 0.6% 55 1.2%
23 Osteosarcoma  86 0.86%  34 0.6% 52 1.1%
24 Liver carcinoma  82 0.8%  35 0.7% 47 1.0%
25 Pleomorphic Sarcoma  61 0.6%  20 0.4% 41 0.8%
26 Leiomyosarcoma  57 0.57%  21 0.4% 36 0.7%
27 Synovial Sarcoma  53 0.5%  24 0.5% 29 0.6%
28 Plasma cell Neoplasm  43 0.4%  15 0.3% 28 0.6%
29 Nose, Paranasal sinuses, nasopharynx carcinoma  43 0.4%  20 0.4% 23 0.5%
30 Metastatic Tumors  508 5.1%  264 5.1% 244 5.0%
31 Miscellaneous malignant Tumor  264 2.6%  170 3.3% 94 1.9%
*Includes lip, tongue, floor of mouth, buccal mucosa, hard palate, upper and lower gingiva; **Central Nervous System (CNS)
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of Hematoxylin and Eosin (H&E) stained slides. Special 
stains e.g. Periodic Acid Schiff Alcian Blue ± diastase, 
reticulin etc. were performed whenever required. A large 
panel of Immunohistochemical stains (IHC) was utilized 
whenever necessary to reach a conclusive diagnosis. 
IHC was used in all cases of Hodgkin and Non Hodgkin 
lymphomas. The latest WHO classifications were used. 
Resection specimens were reported in strict accordance 
with the latest College of American Pathologists (CAP) 
protocols(Washington, 2013) and staged according to 
the most updated TNM classifications.(Edge et al., 2010) 
All relevant data was recorded and analysed using 
the SPSS 19.0 software package. p-values for different 
variables were calculated using the Chi Square and 
Fisher Axact tests. p-value equal to or less than 0.05 was 
considered significant.
Results 
A total of 10,000 consecutive cases of malignant solid 
tumors diagnosed in the Section of Histopathology, AKUH 
in 2014 were included. Out of these, 9492 (94.9%) were 
primary tumors while 508 (5.1%) were metastatic tumors. 
Out of 10,000, 5153 (51.5%) tumors were diagnosed in 
females and 4847 (48.5%) in males. The overall breakup 
is shown in Table 1. The decade wise breakup of the 
commonest malignant tumors in females and males is 
shown in Tables 2 and 3 respectively. The decade wise 
breakup of all 10,000 malignant tumors is shown in 
Table 4.
Breast carcinoma was the commonest malignant 
tumor in females (32%). Out of 1650 cases, 685 (41.5%) 
involved the right breast, 787 (47.7%) involved the left 
and 26 (1.6%) were bilateral. In 152 cases (9.2%), the 
laterality was not known. The decade wise breakup is 
shown in Table 2, while frequency of various histologic 
types is shown in Table 5. Invasive Ductal Carcinoma, 
NOS was the commonest histologic type comprising 
1427 cases (86.5%), this value was statistically significant 
(p-value: <0.0001).
Cancer of the oral cavity was overall the second 
commonest type of malignant tumor (Table 1). Out of a 
total of 1021 cases, 676 (66.2%) occurred in males while 
345 (33.8%) occurred in females. M:F ratio was 1.95:1. 
The p-value (<0.0001) was statistically significant. Cancer 
of the oral cavity included cancer of the buccal (cheek) 
mucosa, floor of mouth, lip, tongue, hard palate and 
oropharynx (hypopharynx). All cases were histologically 
Table 2. Decade-wise Age Distribution of Commonest Malignant Tumors in Females (n=5153)
Age 
Range 
in years 
Breast 
(n=1650)
Oral 
(n=345)
NHL Nodal 
(n=130)
NHL 
Extranodal 
(n=126)
HL 
(n=96)
Esophagus 
(n=362)
Stomach 
(n=139)
Colorectum 
(n=211) Skin (n=201)
Lung 
(n=77)
CNS 
(n=117)
0-10 - - 3 (2.3%) 7 (5.5%) 8 (8.3%) - - - 2 (1.0%) -
12 
(10.2%)
11-20 7 (0.4%) 3 (0.9%) 18 (13.8%) 11 (8.7%) 27 (28.1%) 10 (2.8%) - 11 (5.2%) 2 (1.0%) -
17 
(14.5%)
21-30 148 (9.0%)
15 
(4.3%) 14 (10.8%)
17 
(13.5%)
17 
(17.3%)
46 
(12.7%)
13 
(9.3%) 30 (14.2%) 8 (4.0%) -
32 
(27.4%)
31-40 359 (21.7%)
50 
(14.5%) 14 (10.8%) 15 (11.9%)
15 
(15.6%)
53 
(14.6%)
19 
(13.7%) 35 (16.6%) 20 (10%)
10 
(13%)
19 
(16.2%)
41-50 525 (31.8%)
99 
(28.7%) 20 (15.4%) 29 (23%)
16 
(16.7%)
104 
(28.7%)
28 
(20.1%) 47 (22.3%) 46 (23%)
15 
(19.5%)
15 
(12.8%)
51-60 345 (20.9%)
92 
(26.7%) 34 (26.1%)
27 
(21.4%)
6 
(6.2%)
77 
(21.3%)
36 
(25.9%) 54 (25.6%) 49 (24%)
24 
(31.2%) 11 (9.4%)
61-70 186 (11.3%)
53 
(15.4%) 19 (14.6%)
20 
(15.9%)
6 
(6.2%)
57 
(15.7%)
35 
(25.2%) 25 (11.8%) 48 (24%)
20 
(26%) 10 (8.5%)
>70 80 (4.8%) 33 (9.6%) 8 (6.1%) -
1 
(1.0%) 15 (4.1%) 8 (5.8%) 9 (4.3%) 26 (13%)
8 
(10.4%) 1 (0.8%)
Age 
Range 
in years 
U. 
Bladder 
(n=80)
Ovary 
(n=248)
Endometrium 
(n=187)
Thyroid 
(n=91)
Cervix 
(n=140)
Ewing 
Sarcoma 
(n=56)
G. 
Bladder 
(n=75)
Salivary 
Gland 
(n=33)
Osteosarcoma 
(n=34)
Kidney 
(n=43)
Liver 
(n=35)
0-10 - 6 (2.4%) - - - 10 (17.8%) - - 6 (17.6%) - -
11-20 - 24 (9.7%) - 11 (12.1%) -
29 
(51.8%) - 2 (6.1%) 20 (58.8%) - -
21-30 2 (2.5%) 43 (17.3%) 12 (6.4%)
23 
(25.3%)
8 
(5.7%)
12 
(21.4%) 4 (5.3%) 7 (21.2%) 4 (11.8%) 3 (7%) -
31-40 8 (10%) 33 (13.3%) 11 (5.9%)
23 
(25.3%)
40 
(28.6%) 5 (8.9%) 5 (6.7%) 9 (27.3%) 2 (5.9%) 8 (18%) 2 (5.7%)
41-50 10 (12.5%)
62 
(25%) 43 (23%)
14 
(15.4%)
48 
(34.3%) -
16 
(21.3%) 7 (21.2%) 1 (2.9%)
16 
(37.2%) 6 (17.1%)
51-60 26 (32.5%)
38 
(15.3%) 78 (41.7%) 11 (12.1%)
19 
(13.6%) -
28 
(37.3%) 6 (18.2%) 1 (2.9%)
10 
(23.2%) 14 (40%)
61-70 18 (22.5%)
36 
(14.5%) 32 (17.1%) 6 (6.6%)
20 
(14.3%) -
18 
(24%) - -
4 
(9.3%)
10 
(28.6%)
>70 16 (20%) 6 (2%) 11 (5.9%) 3 (3.2%) 5 (3.6%) - 4 (5.3%) 2 (6.1%) -
2 
(4.6%) 3 (8.6%)
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squamous cell carcinoma of various grades (with 25 
cases or 2.4% showing histologic features consistent 
with sarcomatoid carcinoma- a histologic variant). The 
decade wise breakup is shown in Tables 2 and 3 while 
the site wise breakup is shown in Table 6. As shown in 
Table 6, oral mucosa was the commonest site for oral 
cancers comprising 56.3%.  The p-value was statistically 
significant (<0.0001).
Lymphoma was the second commonest malignant 
tumor in males and the third commonest in females (Table 
1). Out of a total of 974 cases, 622 (63.9%) were diagnosed 
in males and 352 (36.1%) in females. M:F ratio was 1.76:1. 
The p-value was statistically significant (<0.0001). Out of 
974 cases, 733 (75.3%) were Non Hodgkin lymphomas 
(NHL) while 241 (24.7%) were Hodgkin Lymphomas. 
Of the 733 NHLs, 375 (51.2%) were nodal, while 358 
(48.8%) were extranodal. The decade wise breakup in 
males and females is shown in Tables 2 and 3.
Of the 733 NHLs, 477 (65.1%) were diagnosed in 
males, while 256 (34.9%) were diagnosed in females 
(Table 1). The p-value was statistically significant 
(<0.0001). Of the 375 nodal NHLs, 245 (65.3%) were in 
males while 130 (34.7%) were in females. The p-value was 
statistically significant (<0.0001). Of the 358 extranodal 
NHLs, 232 (64.8%) were in males while 126 (35.2%) 
were diagnosed in females. The p-value was statistically 
significant (<0.0001). The sites of involvement of 
extranodal NHL and the histological types of nodal and 
extranodal NHLs are shown in Table 7. Almost 68% of all 
extranodal NHLs were Diffuse Large B Cell Lymphoma 
(DLBCL). The p-value was statistically significant 
(<0.0001).
Out of the 241 cases of Hodgkin lymphoma (HL), 
145 (60.2%) were diagnosed in males while 96 (39.8%) 
were diagnosed in females. The M:F ratio was 1.51:1.0. 
The p-value was statistically significant (<0.0001). The 
decade wise breakup is shown in Tables 2 and 3. Mixed 
cellularity and nodular sclerosis were the commonest 
Table 3. Decade-wise Age Distribution of Commonest Malignant Tumors in Males (n=4847)
Age 
Range 
in 
years 
Oral 
(n=676)
NHL 
Nodal 
(n=245)
NHL 
Extranodal 
(n=232)
HL 
(n=145)
Esophagus 
(n=318)
Stomach 
(n=336)
Colorectum 
(n=384)
Skin 
(n=288) Lung (n=303)
CNS 
(n=239)
0-10 - 9 (3.7%) 16 (6.9%)
34 
(23.4%) - - - 1 (0.3%) - 22 (9.2%)
11-20 4 (0.6%) 22 (9.0%)
37 
(15.9%)
40 
(27.6%) 11 (3.5%) 5 (1.5%) 16 (4.2%) 4 (1.4%) - 22 (9.2%)
21-30 72 (10.6%)
21 
(8.6%)
31 
(13.4%)
31 
(21.4%) 23 (7.2%) 20 (6%) 40 (10.4%)
14 
(4.9%) 3 (1%)
46 
(19.2%)
31-40 119 (17.6%)
44 
(18%)
36 
(15.5%)
12 
(8.3%) 40 (12.6%)
38 
(11.3%) 77 (20.1%)
39 
(13.5%) 13 (4.3%)
56 
(23.4%)
41-50 183 (27.1%)
51 
(20.8%)
31 
(13.4%)
11 
(7.6%) 62 (19.5%)
61 
(18.1%) 76 (19.8%)
47 
(16.3%) 59 (19.5%) 43 (18%)
51-60 166 (24.5%)
33 
(13.5%)
31 
(13.4%) 8 (5.5%) 95 (29.9%)
97 
(28.9%) 82 (21.3%)
74 
(25.7%) 85 (28.18%)
26 
(10.9%)
61-70 84 (12.4%)
49 
(20%)
40 
(17.2%) 7 (4.8%) 55 (17.3%) 74 (22%) 65 (16.9%)
63 
(21.9%) 100 (30%) 21 (8.8%)
>70 48 (7.1%)
16 
(6.5%) 10 (4.3%) 2 (1.4%) 32 (10.1%)
41 
(12.2%) 28 (7.3%)
46 
(16%) 43 (14.2%) 3 (1.2%)
Age 
Range 
in 
years 
U. 
Bladder 
(n=245)
Larynx 
(n=165)
Thyroid 
(n=46)
Kidney 
(n=80)
Testis 
(n=102)
Ewing 
Sarcoma 
(n=36)
G. Bladder 
(n=29)
Salivary 
Gland 
(n=55)
Osteosarcoma 
(n=52)
Liver 
(n=47)
0-10 - - - - 9 (8.8%) 18 (28.6%) - 1 (1.8%) 8 (15.4%) -
11-20 2 (0.8%) - 1 (2.2%) - 15 (14.7%) 30 (47.6%) - 2 (3.6%) 29 (55.8%) 1 (2.1%)
21-30 3 (1.2%) - 9 (19.6%) 1 (1.2%) 36 (35.3%) 9 (14.3%) 1 (3.4%) 6 (10.9%) 8 (15.4%) 2 (4.2%)
31-40 14 (5.7%)
3 
(1.8%) 7 (15.2%)
9 
(11.2%) 27 (26.5%) 2 (3.2%) 2 (6.8%)
8 
(14.5%) 3 (5.8%) 2 (4.2%)
41-50 40 (16.3%)
40 
(24.2%) 7 (15.2%)
23 
(28.7%) 8 (7.8%) 2 (3.2%) 10 (34.5%)
16 
(29.1%) 3 (5.8%)
10 
(21.3%)
51-60 72 (29.4%)
48 
(29.1%)
14 
(30.4%)
24 
(30%) 4 (3.9%) 2 (3.2%) 5 (17.2%)
10 
(18.2%) 1 (1.9%)
16 
(34.1%)
61-70 62 (25.3%)
57 
(34.5%) 6 (13%)
19 
(23.7%) 3 (2.9%) - 7 (24.1%)
10 
(18.2%) -
10 
(21.3%)
>70 52 (21.2%)
17 
(10.3%) 2 (4%) 5 (6.3%) - - 4 (13.8%) 2 (3.6%) - 6 (12.8%)
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histologic subtypes  comprising 103 (42.7%) and 100 
(41.5%) cases respectively. There were 5 cases (2.1%) of 
Nodular lymphocyte predominant HL, 4 cases (1.6%) of 
lymphocyte rich subtype and 1 case (0.4%) of syncytial 
variant. In 28 cases (11.6%), further histologic subtyping 
was not possible and a diagnosis of HL, NOS was 
rendered.
Esophageal carcinoma was the fourth commonest 
malignant tumor overall in both males and females, second 
in females and fifth in males. Out of a total of 680 cases, 
362 (53.2%) were diagnosed in females and 318 (46.8%) 
in males. F:M ratio was 1.41:1.0. Of the 680 cases, 442 
(65%) were located in the lower third of the esophagus 
(statistically significant, p-value: <0.0001), 92 (13.5%) in 
the middle third, and 28 (4.1%) in the upper third. In 118 
cases (17.3%), exact location was not known. As many 
as 660 (97.1%) cases were conventional squamous cell 
carcinomas on histologic examination. This value was 
statistically significant (p-value: <0.0001). There were 16 
(2.3%) adenocarcinomas and 4 (0.6%) cases of basaloid 
squamous cell carcinoma. Out of 680, 215 cases (31.6%) 
were received from Balochistan province bordering Iran 
and China. The decade wise breakup is shown in Tables 
Table 6. Site-wise Distribution of Oral Cavity Cancer 
in both Males and Females (n=1021)
Site Number Percentage (%)
Oral (buccal, cheek) mucosa 575 56.3%
Tongue 224 22%
Lip 59 5.8%
Floor of mouth 58 5.7%
Palate 49 4.8%
Oro/hypopharynx 30 2.9%
Gum 10 0.9%
Not known 16 1.5%
Table 4. Decade Wise Breakup of All Malignant 
Tumors (n=10,000)
Age range (in years) Number Percentage (%)
0-10 245 2.4%
20-Nov 523 5.2%
21-30 902 9.0%
31-40 1421 14.2%
41-50 2169 21.7%
51-60 2235 22.3%
61-70 1733 17.3%
>70 772 7.7%
Table 5. Frequency of Various Histologic Types Of 
Breast Carcinoma and Malignant Ovarian Tumors 
in Females
Histologic type Total No. Percentage (%)
Malignant ovarian tumors (n=248)
Papillary serous carcinoma 74 29.8%
Endometrioid carcinoma 60 24.2%
Mucinous carcinoma 20 8.1%
Clear cell carcinoma 16 6.4%
Poorly differentiated carcinoma 7 2.8%
Dysgerminoma 11 4.4%
Granulosa cell tumor 20 8.1%
Yolk sac tumor 13 5.2%
Malignant mixed germ cell tumor 9 3.6%
Malignant Sertoli-Leydig cell 
tumor 4 1.6%
Juvenile granulosa cell tumor 3 1.2%
Immature teratoma 6 2.4%
Small cell carcinoma 2 0.8%
Squamous cell carcinoma arising 
in cystic teratoma 2 0.8%
Malignant mixed germ cell tumor 1 0.4%
Breast carcinomas (n=1650)
Ductal, NOS 1427 86.5%
Lobular 108 6.5%
Metaplastic 51 3.1%
Mucinous 26 1.6%
Papillary 23 1.4%
Medullary 4 0.2%
Tubular 4 0.2%
Ductolobular 4 0.2%
Tubulolobular 1 0.06%
Adenoid cystic 1 0.06%
Cribriform 1 0.06%
Table 7. Frequency of various Histologic Types of 
Nodal and Extranodal NHL; and Sites of Involvement 
of Extranodal NHLs
Sites of involvement of extranodal NHLs (n=358)
Sites of involvement Total No. Percentage (%)
Stomach 39 10.90%
Colon 32 8.90%
Small intestine 30 8.40%
Bone (predominantly spine) 25 7.00%
Abdomen 19 5.30%
CNS 18 5.00%
Skin 17 4.70%
Tonsil 15 4.20%
Soft tissue 15 4.20%
Oral cavity 14 3.90%
mediastinum 12 3.40%
Nose and nasopharynx 10 2.80%
Face 10 2.80%
Liver 8 2.20%
Retro peritoneum 8 2.20%
Salivary gland 7 1.90%
Lung 6 1.70%
Testis 6 1.70%
Breast 5 1.40%
Female genital tract 5 1.40%
Eye 5 1.40%
Pharynx 5 1.40%
Thyroid 4 1.10%
Mesentery 4 1.10%
Others 16 4.50%
Not known 23 6.40%
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2 and 3.
Colorectal carcinoma was the fifth most common 
malignant tumor overall in both males and females. 
It was the third most common in males and sixth in 
females. Out of a total of 595 cases, 384 (64.5%) were 
diagnosed in males and 211 (35.5%) in females. M:F 
ratio was 1.8:1.0. This value was statistically significant 
(p-value: <0.0001). Of the 595 cases, 448 (75.3%) were 
located in the left and 128 (21.5%) in the right colon. 
The p-value was statistically significant (<0.0001). In 19 
(3.2%) cases, laterality was unknown. All 595 cases were 
adenocarcinomas. The large majority were conventional 
mucin secreting adenocarcinomas which comprised 566 
(95.1%) cases, a value that was statistically significant 
(p-value: <0.0001). Of the remaining 29 cases, 15 (2.5%) 
showed neuroendocrine differentiation, 10 (1.7%) were 
mucinous carcinomas and 4 (0.7%) were signet ring 
adenocarcinomas. A total of 535 (89.9%) out of 595 cases 
were well to moderately differentiated. The decade wise 
breakup is shown in Tables 2 and 3.
A total of 475 cases of gastric carcinoma were 
diagnosed during the study period. Out of these, 336 
(70.7%) were in males and 139 (29.3%) in females. M:F 
ratio was 2.4:1.0. The value was statistically significant 
(p-value: <0.0001). Of the 475 cases, 113 cases (23.8%) 
were located in the proximal and 174 (36.6%) in the distal 
stomach. In 28 cases (5.9%), site of biopsy was given as 
‘body’. As many as 50 cases (10.5%) were located at the 
gastroesophageal junction (GEJ). In 110 cases, (23.1%) 
exact location of the tumor was not known. All 475 
cases were adenocarcinomas. Of these 7 (1.5%) showed 
neuroendocrine differentiation, 2 (0.4%) corresponded 
histologically to mucinous carcinoma, while 1 case 
(0.2%) was diagnosed as hepatoid adenocarcinoma. 
Out of 475, 326 (68.6%) were poorly differentiated 
(signet ring adenocarcinoma or diffuse type) while 149 
(31.4%) were well to moderately differentiated (intestinal 
type adenocarcinomas). The p-value was statistically 
significant (0.002). The decade wise breakup is shown 
in Tables 2 and 3.
A total of 489 cases of skin carcinoma were diagnosed. 
Of these, 288 (58.9%) were diagnosed in males and 201 
(41.1%) in females. M:F ratio was 1.43:1.0. The histologic 
types included squamous cell carcinoma comprising 
253 cases (51.7%), basal cell carcinoma comprising 
152 cases (31.1%), malignant melanoma comprising 55 
cases (11.2%) and cloacogenic carcinoma comprising 7 
cases (1.4%). Other histologic types included adnexal 
carcinomas NOS comprising 9 cases (1.8%), sebaceous 
carcinoma comprising 6 cases (1.3%), 1 case each of 
trichilemmal carcinoma and kaposi sarcoma (0.2%) and 2 
cases of merkel cell carcinoma (0.4%). In 4 cases (0.8%), 
exact histologic type or origin could not be determined. 
The decade wise breakup is shown in Tables 2 and 3.
A total of 380 cases of lung cancer were diagnosed. 
Of these, 303 (79.7%) were diagnosed in males and 77 
(20.3%) in females. M:F ratio was 3.93:1.0. The p-value 
was statistically significant (<0.0001). Out of 380 cases, 
198 (52.1%) involved the right lung and 130 (34.2%) 
involved in left lung. In 52 cases (13.7%), laterality was 
not known. The breakup of the histologic types is shown 
in Table 8.
A total of 356 malignant CNS neoplasms were 
diagnosed. Of these, 239 (67.1%) were diagnosed in 
males while 117 (32.9%) were diagnosed in females. M:F 
ratio was 2.04:1.0. The value was statistically significant 
(p-value: <0.0001). The breakup of the histologic types 
is shown in Table 9.
A total of 325 cases of urinary bladder carcinoma 
were diagnosed during the study period. Of these, 
245 (75.4%) were diagnosed in males and 80 (24.6%) 
in females. M:F ratio was 3.06:1.0. This value was 
Histological type Total No. Percentage (%)
Nodal NHL (n=375)
DLBCL* 182 48.50%
CLL /SLL** 51 13.60%
Follicular lymphoma 36 9.60%
Mantle cell lymphoma 19 5.10%
Precursor T cell NHL 18 4.80%
ALCL*** 17 4.50%
Precursor B cell NHL 14 3.70%
Burkitt lymphoma 14 3.70%
PTCL**** 13 3.50%
Marginal zone lymphoma 5 1.30%
Plasmablastic lymphoma 1 0.30%
NHL, NOS 5 1.30%
"*Diffuse large B cell lymphoma; **Chronic Lymphocytic 
Leukemia /Small Lymphocytic Lymphoma; ***Anaplastic 
Large Cell Lymphoma; ****Peripheral T Cell Lymphoma"
Extranodal NHL (n=358)
DLBCL* 243 67.90%
Burkitt lymphoma 29 8.10%
PTCL** 16 4.50%
ALCL*** 12 3.40%
Pre T ALL**** 12 3.40%
Follicular lymphoma 10 2.80%
Extranodal marginal zone 
lymphoma 9 2.50%
Pre B ALL 7 1.90%
Mantle cell lymphoma 7 1.90%
MALT lymphoma***** 4 1.10%
Mediastinal B cell lymphoma 2 0.60%
IPSID****** 2 0.60%
Hairy cell leukemia 1 0.30%
Angioblastic T cell lymphoma 1 0.30%
Lymphoplasmacytic lym-
phoma 1 0.30%
Mycosis fungoides 1 0.30%
SLL /CLL******* 1 0.30%
"*Diffuse large B cell lymphoma; **Peripheral T Cell 
Lymphoma; ***Anaplastic Large Cell Lymphoma; 
****Acute Lymphoblastic Lymphoma; *****Mucosa 
Associated Lymphoid Tissue; ******Immunoproliferative 
Small Intestinal Disease; *******Chronic Lymphocytic 
Leukemia /Small Lymphocytic Lymphoma"
Table 7 (continued). Frequency of Various Histologic 
Types of Nodal and Extranodal NHL; and Sites of 
Involvement of Extranodal NHLs
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statistically significant (p-value: <0.0001). All 325 cases 
corresponded histologically to urothelial carcinomas. Of 
these, appreciable squamous differentiation was seen in 27 
(8.3%) and glandular differentiation in 22 (6.8%) cases. 
Sarcomatoid areas were seen in 9 cases (2.8%). Out of 
325, 218 (67.1%) were high grade urothelial carcinomas. 
The p-value was statistically significant (<0.0001). 90 
(27.7%) were low grade, while 17 (5.2%) corresponded to 
papillary urothelial neoplasm of low malignant potential. 
Of the 218 high grade tumors, 142 (65.1%) were detrusor 
muscle invasive (statistically in significant, p-value: 
0.2018), 30 (13.8%) were non muscle invasive while no 
detrusor muscle was present in the specimen to assess 
invasion in 46 cases (21.1%).
A total of 270 cases of carcinoma of larynx and 
vocal cord were diagnosed during the study period. Of 
these, 165 (61.1%) were diagnosed in males and 105 
(38.9%) in females. M:F ratio was 1.57:1.0. The value 
was statistically not significant (p-value: 0.063). Of the 
270 cases, 260 (96.3%) corresponded histologically to 
conventional squamous cell carcinoma, while 10 (3.7%) 
were reported as spindle cell carcinoma (sarcomatoid 
carcinoma). The p-value was statistically significant 
(<0.0001).
A total of 248 cases of malignant ovarian tumors were 
diagnosed during the study period. The right ovary was 
involved in 45 cases (18.1%) and the left ovary in 52 cases 
(21%). Bilateral involvement was seen in 59 cases (23.8%). 
Laterality was not known in 92 cases (37.1%). The decade 
wise breakup is shown in Table 2 while the breakup of 
histologic types is shown in Table 5. A total of 179 cases 
of endometrial carcinoma were diagnosed during the study 
period. Of these, 97 (54.2%) were well differentiated, 
75 (41.9%) were moderately differentiated and 7 (3.9%) 
were poorly differentiated. Histologically, 3 out of 179 
(1.7%) corresponded to papillary serous carcinoma and 
1 (0.6%) to clear cell carcinoma. In addition to these 179, 
another 8 (4.3%) endometrial malignant tumors were 
diagnosed which included 3 cases of malignant mixed 
mullerian tumors, 3 cases of endometrial stromal sarcoma 
and 1 case each of adenosarcoma and leiomyosarcoma. 
A total of 140 cases of carcinoma cervix were diagnosed 
during the study period. The overwhelming majority 137 
(97.8%) were histologically consistent with squamous 
cell carcinoma. The p-value was statistically significant 
(<0.0001). Remaining 3 cases (2.2%) were histologically 
consistent with cervical adenocarcinoma. The decade wise 
breakup of malignant endometrial and cervical tumors is 
given in Table 2.
Out of a total of 137 thyroid carcinomas diagnosed 
during the study period, 46 (33.6%) were diagnosed 
in males and 91 (66.4%) in females. This value was 
statistically not significant (p-value: 0.0722). F:M ratio 
was 1.97:1.0. The breakup of histologic types is shown 
in Table 8.
Out of a total of 123 renal cancers diagnosed during 
the study period, 80 (65%) were diagnosed in males 
and 43 (35%) in females. The value was statistically not 
significant (p-value: 0.1488). M:F ratio was 1.86:1.0. 
56 (45.5%) were located in the right and 53 (43.9%) in 
the left kidney. In 2 cases (1.6%), the tumors involved 
both kidneys. In 12 cases (10%), laterality was not 
known. Histologically, 100 out of 123 cases (81.3%) 
were consistent with clear cell renal cell carcinoma. This 
value was statistically significant (p-value: <0.0001). 
Of the remaining 23 cases, 11 (8.9%) were consistent 
with sarcomatoid carcinoma, 8 (6.5%) with papillary 
carcinoma, while 2 cases each (1.6%) were consistent 
with chromophobe renal cell carcinoma and squamous 
cell carcinoma. The decade wise breakup is shown in 
Tables 2 and 3.
Out of 102 malignant testicular tumors, 48 (47.1%) 
were located in the right testis, 29 (28.4%) in the left while 
1 case (1.0%) involved both. In 24 cases (23.5%), laterality 
Table 8. Frequency of Various Histologic Types of Lung Carcinoma, Malignant Salivary Gland Tumors and 
Thyroid Gland Tumors in Males and Females
Primary lung carcinoma in males and females (n=380) Malignant salivary gland tumors (n=88) Thyroid carcinoma (n=137)
Histologic Type
Male (n=303) Female (n=77)
Histologic type
Male (n=55) Female (n=33) Histologic 
type
Male (n=46) Female (n=91)
Number (%) Number (%) Number (%) Number (%) Number (%) Number (%)
Squamous cell 
carcinoma 124 40.90% 20 26%
Mucoepidermoid 
carcinoma 25 45.50% 14 42.40%
Papillary 
carcinoma 27 58.70% 52 57.10%
Adenocarcinoma 117 38.60% 42 54.50% Adenoid cystic carcinoma 11 20.00% 10 30.30%
Papillary 
carcinoma, 
follicular 
variant
7 15.20% 10 11.00%
Small cell 
carcinoma 46 15.20% 9 11.70%
Polymorphous 
low grade 
carcinoma
6 10.90% 3 9.10% Follicular carcinoma 6 13.00% 11 12.10%
Large cell neuroen-
docrine carcinoma 4 1.30% 1 1.30%
Carcinoma ex 
pleomorphic 
adenoma
5 9.10% 2 6.10% Anaplastic carcinoma 3 6.50% 7 7.70%
Adenosquamous 
carcinoma 4 1.30% 2 2.60%
Acinic cell 
carcinoma 2 3.60% 1 3.00%
Medullary 
carcinoma 3 6.50% 6 6.60%
Sarcomatoid 
carcinoma 2 0.70% 1 1.30%
Myoepithelial 
carcinoma 2 3.60% 2 6.10%
Insular carci-
noma -- -- 3 3.30%
Undifferentiated 
large cell 
carcinoma
1 0.30% -- -- Malignant mixed tumor 1 1.80% 1 3.00%
Hurthle cell 
carcinoma -- -- 2 2.20%
Non-small cell 
carcinoma, NOS 4 1.30% 1 1. 3%
Poorly 
differentiated 
carcinoma
1 1.80% -- --
Bronchoalveolar 
carcinoma 1 0.30% 1 1. 3% Carcinosarcoma 2 3.60% -- --
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was not known. Seminoma and malignant mixed germ cell 
tumors were the commonest histologic types comprising 
44 (43.1%) and 35 (34.3%) cases respectively. Other types 
including Yolk Sac tumor (14 cases, 13.7%), immature 
teratoma (6 cases, 5.9%), embryonal carcinoma (2 cases, 
1.9%) and malignant sertoli cell tumor (1 case, 1%). The 
decade wise breakup is shown in Table 3.
A total of 237 cases of prostatic adenocarcinoma were 
diagnosed in the study period. Average Gleason grade 
(score) was 6 in 41% and 7 in 39%. Average tumor volume 
was 60 to 65%. Perineural invasion was present in 110 
cases (46.4%). Out of 237 cases, 9 patients (3.8%) were 
under 50 years of age, 43 (18.2%) were between 51 and 
60, 105 (44.3%) were between 61 and 70 and 80 (33.7%) 
were above 70 years of age.
Out of a total of 119 cases of Ewing sarcoma 
diagnosed, 63 (52.9%) were diagnosed in males and 56 
(47.1%) in females. M:F ratio was 1.12:1.0. Of the 119 
cases, 52 (43.7%) were bone based while 63 (52.9%) 
were soft tissue based. In 4 cases (3.4%) location was 
not known. The decade wise breakup is given in Tables 
2 and 3.
As many as 75 (72.1%) out of 104 Gall bladder 
carcinomas were diagnosed in females while 29 (27.9%) 
were diagnosed in males. This value was statistically 
significant (p-value: <0.0001). In 101 cases (97.1%), 
the tumor invaded full thickness of the wall and invaded 
the peri-muscular connective tissue. This value was 
statistically significant (p-value: <0.0001). In 35 cases 
(33.6%), the tumor perforated the serosa (visceral 
peritoneum) and directly invaded the liver or another 
organ. Cystic duct resection margin was positive in 21 
cases (20.2%). In 3 cases (2.9%), specimen was received 
in multiple pieces and it was not histologically possible to 
determine the extent of tumor invasion. The decade wise 
breakup is given in Tables 2 and 3.
A total of 88 malignant salivary gland tumors were 
diagnosed. Of these, 55 (62.5%) occurred in males and 
33 (37.5%) in females. The p-value was statistically not 
significant (0.0838). The M:F ratio was 1.66:1.0. The 
decade wise breakup is given in Tables 2 and 3 while 
histologic types are shown in Table 8.
Of the 86 cases of osteosarcoma, 52 (60.5%) were 
diagnosed in males and 34 (39.5%) in females. M:F ratio 
was 1.53:1.0. Femur and tibia were the commonest sites 
comprising 25 (29.1%) and 24 (27.9%) cases respectively. 
Other bones involved were humerus (7 cases, 8.1%), 
radius (5 cases, 5.8%), ileum (4 cases, 4.6%), fibula (4 
cases, 4.6%), rib (3 cases, 3.5%), jaw (2 cases, 2.3%), 
ulna (2 cases, 2.3%) and foot (2 cases, 2.3%). In 8 cases 
(9.3%), exact location was not known. The decade wise 
breakup is given in Tables 2 and 3.
Of the 82 cases of hepatocellular carcinoma seen 
during the study period, 47 (57.3%) were diagnosed in 
males and 35 (42.7%) in females. M:F ratio was 1.3:1.0. 
All cases were diagnosed on core biopsies. As many as 
80 (97.6%) were histologically well differentiated. This 
value was statistically significant (p-value: <0.0001). The 
decade wise breakup is given in Tables 2 and 3.
Discussion
Carcinoma of the oral cavity, lymphoma (Non Hodgkin 
and Hodgkin combined) and esophageal carcinoma 
were among the top five malignancies in both males and 
females. Breast cancer was the commonest cancer in 
females (32% of all malignancies in females) and it was 
overall the single most common type of cancer reported. 
In males, colorectal and gastric carcinomas rounded off 
the top five. In females, ovarian carcinoma completed the 
top five while colorectal carcinoma, fifth overall in both 
sexes combined, was at number six. Lung cancer, among 
the top three cancers in most international studies was 
eighth overall in our series, sixth in males and fifteenth in 
females. The lower incidence in females can be attributed 
to smoking habits (women in Pakistan smoke much less 
compared to women in other parts of the world). Gastric 
carcinoma, fourth in males was at seventh place overall 
due to its lower (tenth) place in females. Skin cancer was 
Table 9. Histologic Types of Malignant CNS Neoplasms 
in Both Males and Females (n=356)
Histologic type Total No. Percentage (%)
Diffuse Astrocytoma, Grade II 4 1.1%
Anaplastic Astrocytoma, Grade 
III 3 0.8%
Glioblastoma Multiforme, Grade 
IV 76 21.3%
Oligodendroglioma, Grade II 54 15.2%
Anaplastic oligodendroglioma, 
Grade III 72 20.2%
Ependymoma, Grade II 19 5.3%%
Anaplastic Ependymoma, Grade 
III 16 4.5%
Atypical Meningioma, Grade II 26 7.3%
Anaplastic Meningioma, Grade 
III 3 0.8%
Medulloblastoma, Grade IV 31 8.7%
CNS PNET, Grade IV * 5 1.4%
Gliosarcoma, Grade IV 6 1.7%
Glioblastoma with 
oligodendroglioma Component 
(GBMO), Grade IV
15 4.2%
Anaplastic Oligoastrocytoma, 
Grade III 8 2.2%
Oligoastrocytoma, Grade II 1 0.3%
Pleomorphic Xanthoastrocytoma, 
Grade II 6 1.7%
Central Neurocytoma, Grade II 3 0.8%
Atypical Choroid Plexus 
Papilloma, Grade II 1 0.3%
Pineocytoma, Grade II 1 0.3%
Ganglioglioma, Grade II 1 0.3%
AT/RT, Grade IV ** 2 0.6%
Hemangioblastoma, Grade II 1 0.3%
Anaplastic Hemangiopericytoma, 
Grade III 2 0.6%
* Primitive Neuroectodermal Tumor; ** Atypical Teratoid and Rhabdoid 
Tumor
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very common occupying sixth place overall and seventh 
place in both sexes. Malignant tumors of the CNS occupied 
ninth place overall in our series, and ninth and eleventh 
place in males and females respectively. Carcinoma of 
the urinary bladder was at tenth place overall, eighth 
in males and fourteenth in females. Carcinomas of 
endometrium and cervix occupied the eighth and ninth 
places in females. In males, prostatic carcinoma, among 
the top three malignancies in most series was at number 
ten. Cancer of larynx and vocal cord occupied eleventh 
place overall, eleventh in males and twelfth in females. 
A comparison with incidence rates of different cancers 
around the world is at this point warranted. Across Asia, 
the incidence rates vary greatly and there are significant 
(three fold) differences in both sexes.(Shin et al., 2010) In 
Thailand, lung cancer was the commonest cancer in both 
males and females but in a particular region of Thailand, 
liver cancer was the commonest. In females, breast and 
cervical cancer were the most common while oral and 
pharyngeal cancers were also extremely common in both 
sexes. This variability in the incidence of various types of 
cancers even within different regions of the same country 
results from different risk factors prevalent in different 
regions to which the populations of particular areas are 
exposed.(Sriplung et al., 2005) In Thailand, colorectal and 
breast cancers showed a statistically significant increasing 
trend in the 1990s while incidence rates of other cancers 
remained sTable.( Sriplung et al., 2005) In India, lung, 
esophagus, stomach, oral and pharyngeal cancers were 
the commonest cancer types in males while cancers 
of cervix and breast followed by oral cavity, stomach 
and esophagus were the predominant cancer types in 
females.(Murthy et al., 2008) A report using data from 
India’s National Cancer Registry Program showed that 
the incidence of various types of cancers in India was 
increasing in both sexes and that increase in population 
size, increase in the number of elderly people, urbanization 
etc. were responsible for this increasing cancer burden. It 
noted that the existing diagnostic and treatment facilities 
were inadequate to tackle the present cancer load and 
recommended that these facilities be urgently strengthened 
and increased to handle the cancer load which is expected 
to increase consistently till 2026.(D’Souza et al., 2013) It 
is unfortunate that in Pakistan, there is not even a regional 
cancer registry, what to say of a national one. Our situation 
is identical to India in terms of rising cancer burden and 
grossly inadequate diagnostic /treatment facilities but 
tragically, we do not have the data to determine the exact 
magnitude of an undeniably grim situation. Past and recent 
attempts to develop regional cancer registries were not 
very successful.
Data from two population based registries in Ibadan 
and Abuja regions in Nigeria showed that breast and 
cervical cancers were the commonest cancers in females 
while carcinoma of the prostate was the commonest cancer 
in males. About 66% cancers were seen in females.(Jedy-
Agba et al., 2012) In Malawi, almost 60% cancers were 
seen in females. Cancer of cervix was the commonest 
followed by kaposi sarcoma, cancers of esophagus, breast 
and non-Hodgkin lymphoma. In males, Kaposi sarcoma 
was the commonest followed by cancer of esophagus, 
non-Hodgkin lymphoma and cancers of prostate and 
urinary bladder. Cervical cancer accounted for over 45% 
of all cancers in females, while Kaposi sarcoma accounted 
for almost 51% of all cancers in males. Even in females, 
Kaposi sarcoma comprised over 21% of all malignancies. 
Surprisingly, the incidence of breast carcinoma was very 
low in Malawi (4.6%), a figure much lower than anywhere 
else in the world.(Msyamboza et al., 2012)
Unlike other studies from Asia and Africa, where 
carcinoma of cervix was among the top most malignancies, 
it was the ninth most common cancer in females in our 
series accounting for 2.7% of all cancers in females. This 
low incidence of carcinoma cervix may reflect low sexual 
promiscuity in Pakistani women.
In Europe, data from a population based cancer registry 
in Cyprus- a Mediterranean country with a unique cultural 
and environmental setting- prostate, lung, colorectal and 
bladder cancers were the commonest in males, while 
breast, colorectal, uterine and thyroid cancers were the 
commonest cancers in females. This study found that the 
overall cancer incidence in Cyprus was lower compared 
to the other countries in the region.(Cooter et al., 2015) A 
study by the Italian network of cancer registries showed 
that cancer incidence was increasing in both sexes. 
However, mortality from cancer was decreasing. Prostate 
and lung cancer were the commonest cancers in Italian 
males while breast cancer accounted for about one-fourth 
of all cancers in females.(AIRT Working Group, 2006) 
In general, the incidence of cancers is increasing 
worldwide, although incidence of specific types has 
stabilized in the developed countries. Mortality from 
cancer is decreasing in the developed world. This is unlike 
the developing world where both cancer incidence and 
cancer mortality are increasing, while the infrastructure 
to fight cancer is grossly inadequate.
A recent study from Germany(Bahr et al., 2015) 
showed that the number of new cancer cases in Germany 
will go on increasing at least up to 2020 and that the 
number of hospital days and sickness costs will increase. 
In North America, data from a study on epidemiology 
of cancer in United States(Cresanta, 1992) demonstrated 
that just four cancers (breast, lung, prostate and colorectal) 
accounted for 56% of all cancer related mortality. The 
study highlighted genetic and environmental factors 
important in specific types of cancer for example cigarette 
smoking and tobacco abuse (in cancer of lung, oral cavity, 
larynx, esophagus, pancreas, urinary bladder, kidney), 
young black women (breast), black men (lung & prostate), 
young whites with excessive sun exposure (malignant 
melanoma), and the elderly (colorectal cancer). US 
data focusing on cancer trends between 1975 and 2000 
showed that incidence of all cancers in the US increased 
from the mid-seventies upto 1992, rates then decreased 
between 1992 and 1995 and finally stabilized between 
1995 and 2000. Similarly, mortality rates from all cancer 
sites declined from 1994 to 1998 and then stabilized from 
1998 through 2000.(Weir et al., 2003) Yearly US cancer 
statistics compiled by the American Cancer Society 
based on the most recent data on cancer incidence and 
mortality demonstrated that incidence and mortality rates 
from all cancer sites continued to decrease from 2000 
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onwards in males. However, incidence rates continued 
to increase by about 0.3% per year in females from 1995 
through 2003. Mortality rates continued to decrease for 
the three commonest cancers in males (lung, colorectum 
and prostate) as well as for the commonest cancers in 
females (breast and colorectum). In 2004, cancer death 
rates in males and females fell by 18.4 % and 10.5% 
respectively compared to the nineties. Cancer incidence 
rates in females began to fall around 2000 by about 0.6% 
per year through 2005. Cancer mortality rates in males 
declined by 19.2% between 1990 and 2005 and about 
80% of the decrease was due to decreased mortality from 
lung, prostate and colorectal cancers. Similarly, mortality 
rates in females declined by 11.4 % and about 60 % of 
the total decrease was due to decreased mortality from 
breast and colorectal cancers. The decline in cancer 
mortality rates in the United States over a 16 year period 
resulted in the avoidance of around 767,000 deaths. This 
figure emphasizes the importance of disseminating our 
current knowledge of cancer in all segments of population 
and the importance of supporting new advancements in 
cancer prevention techniques as well as early detection 
and treatment of cancer. (Jemal et al., 2004; Jemal et al., 
2006; Jemal et al., 2007; Jemal et al., 2008; Jemal et al., 
2009; Jemal et al., 2010)
As shown in Table 4, a total of 768 out of 10,000 
malignant tumors (7.7%) were diagnosed in patients upto 
20 years of age. The most frequent in this age group were 
Non-Hodgkin Lymphoma (123), Hodgkin Lymphoma 
(109), Ewing Sarcoma (87), malignant CNS tumors (73) 
and Osteosarcoma (63 cases). Other tumors diagnosed 
frequently in young patients included rhabdomyosarcoma 
(37 cases), ovarian malignant tumors (30), Synovial 
sarcoma (26), testicular malignant tumors (25), Wilm’s 
tumor (22), neuroblastoma (20) and retinoblastoma (19 
cases).  It is important to remember that only solid tumors 
were included in our study and leukemias (extremely 
common in the young) were not included. In the US, 
solid tumors of the CNS were the commonest malignant 
tumors in children up to age of 14 years.(Cresanta, 1992) 
In Brazil, the commonest malignant tumors in children, 
based on fourteen population based cancer registries, 
were lymphomas and CNS tumors.(de Camargo et al., 
2010) However, in both US and Brazil, leukemia was 
the commonest malignancy in children and adolescents.
(Cresanta, 1992; de Camargo et al., 2010) In Shanghai, 
China, based on data from the population based Shanghai 
Cancer Registry, the five commonest solid malignant 
tumors in children up to the age of 14 years were malignant 
CNS tumors, lymphomas, malignant germ cell tumors, 
neuroblastoma and soft tissue sarcoma. The incidence rate 
for malignant tumors was the highest in the first five years 
of life.(Bao et al., 2013) In Italy, data AIRTUM showed 
that cancer incidence was greater in the 0-14 than in the 
15-19 year age group. Leukemias were the commonest 
malignances. Among solid tumors, Non Hodgkin 
and Hodgkin lymphoma, malignant CNS tumors and 
neuroblastomas were the commonest. Cancer incidence 
rates were decreasing in the 0-14 year age group, while 
they were still increasing in the 15-19 year age group. 
However, cancer mortality showed a persistent decline in 
both age groups.(AIRTUM Working Group, 2013) These 
studies show that, similar to our study, malignant CNS 
tumors are common in children and adolescents. Data 
on childhood CNS tumors from 13 Eastern and Southern 
European Cancer registries showed that astrocytomas 
constituted the most common malignant CNS tumors in 
the age groups 0-14 years (30%) followed by embryonal 
tumors (26%).(Papathoma et al., 2015)
As seen in Table 4, malignant tumors were most 
common in the 31 to 70 year age group reaching a peak 
in the 41 to 60 year age group.
Breast cancer is the commonest type of cancer and 
the commonest cause of death from cancer in women 
worldwide.  Its incidence is highest in North America and 
Europe and low in Asia and Africa.(Parkin et al., 2001) 
However, as seen in Tables 1 and 2, this is not the case 
in Pakistan. It was the most common cancer in women 
comprising 32% of all cancers diagnosed in women. It 
was slightly more common in the left breast i.e. 47.7% 
compared to 41.5% in the right breast. As shown in 
Table 5, over 72% cases were diagnosed in the age range 
31 to 60 years. Invasive Ductal Carcinoma, NOS was 
the commonest histologic type comprising 86% of all 
cases (Table 5). This figure was higher than the figure of 
approximately 75% reported in some studies.(Berg and 
Hunter, 1995) 
In the United States, the incidence and death rate from 
breast cancer are constantly declining.(Jemal et al., 2009; 
Jemal et al., 2010) In our neighboring India, breast cancer 
has replaced cancer of cervix as the commonest in females 
especially in urban areas where it comprises 30 to 40% 
of all cancers in women.(Nanda Kumar et al., 2010) This 
change from cervix to breast occurred in just over a decade 
(1990 to 2003). The incidence rate of cancer of cervix is 
decreasing while that of breast cancer is increasing.(Takiar 
and Srivastav, 2008) 
The high incidence of oral cancer in both sexes is 
related to the widespread ingestion of paan (betal quid), 
chalia, naswaar; cigarette, cigar and hooka smoking; 
poor oral hygiene etc. As shown in Tables 2 and 3, oral 
cancer was commonest in the fifth and sixth decades of 
life. The inner cheek (buccal) mucosa was the commonest 
site in the oral cavity followed by the tongue. (Table 
6). Mouth and tongue cancer is very common in the 
subcontinent, where many of the major risk factors such 
as cigarette or bidi smoking, betal quid chewing, tobacco 
chewing etc are rampant. It is no wonder that the highest 
incidence rates of oral cancer in females are found in 
the Indian subcontinent.(Snkaranarayanm et al., 1998) 
In India, studies have shown regional differences in the 
incidence rates of oral cancers in both males and females 
according to data from registries in different regions of 
the country.(Yeole, 2007) One study showed that buccal 
mucosa was the commonest site of oral squamous cell 
carcinoma comprising 63.7% followed by retro molar 
area comprising 15%. This study also concluded that 
the incidence rates of oral cancer vary widely according 
to geographic location. However, it emphasized that 
even within one location, other factors such as age, sex, 
site, habit etc cause further variation in incidence rates.
(Sharma et al., 2010) The US National Cancer Institute’s 
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SEER data showed that incidence rate as well as five 
year survival rate from oral cancer had remained constant 
inspite of advances in surgery and radiation. The study 
emphasized that early detection of localized lesions with 
appropriate treatment and aggressive counseling of the 
public to prevent use and give up smoking and alcohol 
were extremely important in decreasing the morality rates 
from oral cancer.(Silverman, 2001)
Israel is another country with very high incidence 
rates of oral cancer. Data from the Israel National Cancer 
Registry showed that squamous cell carcinoma in males 
was extremely common above age 55 years.(Zini et al., 
2010) A large population of fair skinned people and 
high level of sun exposure have resulted in the lip being 
the commonest site for oral cancer comprising 36.8%.
( Zini et al., 2010) In Israeli Arabs, most cases of oral 
cancer occurred in males (high level of smoking), mean 
age was 54.4 years, oropharynx was the commonest site 
(28.3%), while squamous cell carcinoma was the most 
common histologic type.( Zini et al., 2012) All the above 
studies on oral cancer from around the world demonstrate 
geographical and regional variations in incidence rates, 
and also show considerable variation in the commonest 
exact site depending on multiple factors including habit, 
tobacco and alcohol , exposure to sun etc. 
Lymphomas were among the three commonest 
malignancies in both males and females. They were 
more common in males and over 75% were non Hodgkin 
lymphomas (NHL). Nodal were more common (51.2%) 
than extra nodal NHLs (48.8%). Nodal NHLs in both 
sexes were most common in the fourth to seventh 
decades, whereas extra nodal NHLs were more evenly 
distributed from the second to seventh decades of life.  The 
gastrointestinal tract (stomach, small intestine, and colon) 
was the commonest site of extranodal NHLs followed by 
bone. Diffuse Large B Cell Lymphoma (DLBCL) was the 
commonest histologic type of NHL, comprising 48.5% of 
nodal and almost 68% of extra nodal NHLS.   
Hodgkin lymphoma (HL) was most common in 
the first to third decades of life in males. However, it 
occurred at a somewhat older age in females with most 
cases in the second to fifth decades. Mixed Cellularity and 
Nodular Sclerosis histologic subtypes were almost equally 
common. Italian cancer figures reported that incidence 
of HL was increasing in women although mortality from 
HL decreased significantly in both males and females. 
(AIRT Working Group, 2006)  In the United States, acute 
lymphoblastic leukemia was the commonest malignancy 
in children up to the age of 14 years.(Cresanta, 1992) In 
our study, precursor B and T lymphoblastic lymphomas /
acute lymphoblastic leukemias accounted for almost 14 % 
of all NHLs (Table 7). A study from Jordan showed similar 
results with NHLs comprising over 78.4 % and extra nodal 
lymphomas 30.5% of all lymphomas.(Haddadin, 2005) 
In our series, NHL comprised over 75% and extranodal 
lymphomas 30.5% (identical to the figures from Jordan) 
of all lymphomas. There is a strikingly evident but 
unexplained male predominance in many lymphoma 
subtypes in all age groups and autoimmune diseases 
are associated with increased risk for development of 
lymphomas especially in females.(Roman and Smith, 
2011) This marked propensity of NHLs for males in both 
children and adults was also noted in  two recent studies 
from United Kingdom, which also demonstrated that 
males were usually diagnosed at younger ages compared 
to females. However, no survival difference was detected 
between males and females.(Smith et al., 2011; Smith et 
al., 2015)
Esophageal carcinoma was the second commonest 
malignancy in women. As many as 53.2% esophageal 
carcinomas in our series were diagnosed in women. In 
65% cases, the tumor was located in the lower third of 
the esophagus. Over 97% were squamous cell carcinomas 
on histologic examination. Over 66% were diagnosed in 
the fifth, sixth and seventh decades of life (Tables 2 and 
3). These findings were similar to our earlier findings.
(Ahmad et al., 2013) Over 31% cases were received from 
Baluchistan province along Pakistan’s borders with Iran, 
Afghanistan and China. The above mentioned geographic 
region has well documented high rates for esophageal 
cancers in both males and females.(Curado et al., 2013)
Colorectal carcinoma was much more common 
in males (64.5%). Over 75% were located in the left 
colon especially in the sigmoid and rectum. All cases 
corresponded histologically to adenocarcinomas. 
Colorectal carcinoma was most commonly diagnosed in 
the fourth to seventh decades of life. Our earlier study 
showed similar findings with almost 63% occurring in 
males and over 80% in the left colon.(Ahmad et al., 2013)
Gastric Carcinoma was also much more common 
in males. Almost 71% occurred in males. Almost 
37% were located in the distal stomach. All cases 
were adenocarcinomas and almost 69% were poorly 
differentiated signet ring adenocarcinomas on histologic 
examination.  In our earlier study, over 67% occurred in 
males, 62% were located in the distal stomach and over 
74% were poorly differentiated signet ring carcinomas.
(Ahmad et al., 2013) Helicobacter pylori infection is very 
common in Pakistan and it is among the high prevalence 
countries for H pylori infection.(Khan et al., 2013) This is 
probably an important etiologic factor contributing to the 
high incidence rates of gastric cancer in Pakistan. 
Although we do not have exact figures, the incidence 
of cancers of esophagus, stomach and colon are increasing 
in Pakistan. Esophageal cancer is extremely common 
worldwide and has a high mortality rate.(Herszenyi 
and Tulassay, 2010) Incidence and mortality rates have 
recently shown a reducing trend in some parts of the world.
(Xie et al., 2012) However, in Asia, the incidence and 
mortality rates remain high.(Lin et al., 2013; Bafandeh 
et al., 2006) The incidence and mortality rates associated 
with gastric cancer remain very high in developing 
countries.(Miwa et al., 2002) However, these rates have 
decreased significantly in many developed countries.
(Crew and Neugut, 2006) Gastric cancer remains very 
common in East Asia, Eastern Europe and in Central and 
South America.(Herszenyi and Tulassay, 2010) In both 
United States and Italy, incidence and death rates for 
gastric and colorectal cancers have shown a significant 
decrease in both sexes.(AIRT Working Group, 2006; 
Jemal et al., 2010) However, colorectal cancer remains 
one of the commonest cancers worldwide with the highest 
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incidence rates in developed countries in North America, 
Europe, Australia and New Zeeland and remains a leading 
cause of death, with obesity and physical inactivity as 
important contributing factors. Although its incidence is 
considered to be low in Asia, Africa and South America 
(poor or developing countries),(center et al., 2009) 
this is not our experience. It exacts a heavy toll in both 
morbidity and mortality in Pakistan. Developed Asian 
countries like Hong Kong, continue to show increased 
incidence rates for colorectal cancer(Xie et al., 2012) 
and developing countries like Iran and Thailand also 
demonstrate increased incidence rates in both males and 
females.(Khuhaprema and Srivatanakul, 2008; Abdifard 
et al., 2013) 
Skin cancer was common in both sexes. Almost 
59% were diagnosed in males. The large majority were 
diagnosed from the fourth decade onwards (Tables 2 
and 3). The three commonest histologic types were 
squamous cell carcinoma (51.7%), basal cell carcinoma 
(31.1%) and malignant melanoma (11.2%). This is in 
contrast to western data which indicate that BCC is the 
commonest histologic type (approximately 70%) followed 
by SCC.(52,53)  In Pakistan, although there is severe sun 
exposure, the large majority of people are dark-skinned. 
The incidence of these cancers is directly related to the 
amount of sun exposure and the lack of melanin pigment 
in the skin.(Casson, 1980, Crowson, 2006)  However, the 
low incidence of malignant melanoma, as compared to 
the west where it is among the ten commonest malignant 
tumors in both males and females(Jemal et al., 2010) is 
in accordance with the well-known fact that these tumors 
mainly occur with excessive sun exposure in fair skinned 
people who have very little melanin pigment in their skin.
(Beral et al., 1983) 
Lung cancer was at number six among males. 
However, it was much less frequent in females (Tables 2 
and 3), most likely due to the fact that cigarette smoking 
is much less common in Pakistani women compared 
to the west. Pakistani women are more likely to smoke 
huqqa, a tobacco preparation. Huqqa smoking is more 
prevalent in women living in rural areas compared to 
those living in cities. Even among males, lung cancer 
was much less common compared to the West where it 
remains the commonest cancer in both sexes. In the US, 
at least among males, its incidence rate and mortality are 
decreasing.(Jemal et al., 2010) Italian figures also show 
a decrease in mortality rate from lung cancer in males. 
However in Italian women, the incidence of lung cancer 
is increasing.(AIRT Working Group) In US women, the 
mortality rates from lung cancer were increasing in those 
states where prevalence of smoking was higher.(Jemal et 
al., 2008) Lung cancer remains a deadly and devastating 
disease worldwide and five year survival rates remain 
under 20%.(Williams and Sandler, 2001) In our series, 
the majority of cases in both males and females occurred 
in the fifth, sixth and seventh decades of life (Tables 2 
and 3). It was much more common in males (79.7%). The 
right lung was involved more commonly (51.2% cases). 
Among histologic types, squamous cell carcinoma and 
adenocarcinoma were almost equally represented, while 
small cell carcinoma comprised just over 15% (Table 
8). A recent Study from Poland showed that lung cancer 
accounted for almost half of all cancer related deaths in 
people above 65 years of age.(Radziszewska et al., 2015) 
An interesting study from Guangzhou, China showed 
that apart from the major risk factors like smoking, air 
pollution and certain occupational hazards, other less 
well documented risk factors such as degree of indoor air 
pollution, general conditions in homes, cooking practices 
and cooking environment, size of the kitchen etc. were 
important especially in relation to the development of 
lung cancer in nonsmoking females. This study also made 
the interesting observation that consumption of fresh 
vegeTables was a protective factor for lung cancer in both 
genders.(Du et al., 1996) 
Malignant tumors of larynx and vocal cord were also 
common. Cancer of larynx was much more common 
in males (61%). The large majority of cases in both 
sexes were diagnosed in the fifth, sixth and seventh 
decades of life (Tables 2 and 3). Over 96% corresponded 
histologically to squamous cell carcinoma. According to 
Western data, cancer of larynx accounts for 2.2% of all 
cancers in males and 0.4% in females, most cases are 
diagnosed in the fifth decade of life and beyond and almost 
96% patients are males.(Rafferty et al., 2001) In our study, 
compared to western data, the tumor was more common in 
females accounting for 2.7% of all cancers in both genders, 
3.4% of all cancers in males and just over 2% of all cancers 
in females (Tables 1 to 3). Cigarette smoking is a major 
risk factor for cancer of larynx.(Muscat and Wynder, 1992) 
However, tobacco abuse in other forms is also a major risk 
factor(Cresanta, 1992) and the smoking of huqqa (a form 
of tobacco) especially in rural areas probably accounts for 
increased incidence rate of laryngeal cancer in Pakistani 
women compared to the west. 
Ovarian cancer was among the five commonest cancers 
in females. Papillary serous carcinoma and endometrioid 
carcinoma were the commonest histologic types. Ovarian 
malignant tumors were evenly distributed in the third to 
seventh decades of life with a peak in the fifth decade. 
Almost 12% occurred in patients 20 years or younger 
(Table 2). The incidence of ovarian carcinoma has 
remained relatively constant around the world.  However, 
recent Italian figures showed a decrease in incidence.
(AIRT Working Group, 2006) According to US Cancer 
Statistics, 2010,(Jemal et al., 2010) ovarian cancer was 
the ninth commonest cancer in women accounting for 
3% of all cancers in women and was the fifth commonest 
cause for death from cancer in women accounting for 5% 
of all deaths. In our series, ovarian cancer accounted for 
4.8% of all cancers in women (Table 2). Ovarian cancer 
is responsible for the greatest number of deaths resulting 
from malignant tumors of the female genital tract.
(Cannistra, 2004) Since ovarian cancer has a high case-
fatality ratio (due mostly to late diagnosis), recent studies 
have attempted to build risk prediction models which 
can help identify women at increased risk. Such women 
can benefit from targeted prevention measures such as 
screening or chemo preventive drugs.(Li et al., 2015)
Malignant CNS neoplasms were surprisingly common 
accounting for almost 5% of all malignant tumors in males 
(Table 3) and over 3.5% overall (Table 1). Over 67% were 
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diagnosed in males. Glioblastoma Multiforme (GBM) and 
grade II and III oligodendrogliomas were the commonest 
CNS malignancies comprising almost 57% of all cases. 
Medulloblastoma was the commonest malignant CNS 
neoplasm in children. The majority of malignant CNS 
tumors were diagnosed in the third to sixth decades of 
life in males and in the second to fifth decades in females. 
However, over 18% in males and almost 25% in females 
occurred in patients younger than 20 years of age (Tables 
2 and 3). In the United States, diffuse astrocytomas were 
the most common primary intracranial tumors comprising 
almost 60% and approximately 8% of these were GBMs. 
Oligodendrogliomas, grades II and III accounted for only 
4% of primary intracranial tumors.(CBTRUS, 2008) In 
our series, grade II and III oligodendrogliomas comprised 
over 35% of all primary brain tumors while grade II , III 
and IV astrocytomas comprised just over 23% of which 
the large majority were GBMs (Table 9). However, in a 
previous study performed in our department, the number 
of astrocytic and oligodendroglial neoplasms was almost 
equal.(Zubair et al., 2011) 
Urinary bladder cancer was very common in males. 
It was the eighth commonest malignancy in males and 
fourteenth commonest in females. Over 75% cases 
were diagnosed in males. All cases were histologically 
consistent with urothelial carcinoma. Over 67% were 
high grade cancers of which over 65% of which were 
detrusor muscle invasive. This figure could be higher 
since in over 21% cases, no deep muscle was present in 
the biopsy to assess muscle invasion. International studies 
show that bladder cancer is the seventh commonest cancer 
worldwide accounting for about 3.2% of all cancers and 
is more than three times more common in males than 
females with a worldwide M:F ratio of 3.5:1.(Parkin et 
al., 1994; Ferlay et al., 2001) According to US Cancer 
Statistics 2010,(Jemal et al., 2010) bladder cancer was the 
fourth commonest cancer in males accounting for 7% of all 
cancers However, mortality wise it was ninth accounting 
for 3% for all cancer deaths in males. According to Italian 
Cancer Figures 2006,(AIRT Working Group, 2006) 
incidence and mortality rates of bladder cancer decreased 
in males. In both males and females, bladder cancer is 
most prevalent in North America, Western Europe and 
Australia.(Pisani et al., 2002; Parkin et al., 2003) Although 
considered to be much more common in developed 
compared to developing countries, it ranked among the 
commonest malignancies in males in our series (Table 3). 
Tobacco smoking is a major risk factor in the development 
of bladder cancer and the risk of developing bladder cancer 
is several times higher in smokers than in non-smokers. 
Like lung cancer, the risk is also proportionate with the 
number of cigarettes smoked and the duration of smoking.
(Brennan et al., 2000; Negri and La Vecchia, 2001)
Prostate cancer was the tenth commonest cancer in 
males comprising 4.8% (Table 3). It is the sixth most 
common cancer worldwide(Parkin, 2001) comprising 
9.7% of all cancers in males. It is more common in the 
developed countries comprising over 15% and less so 
in the developing countries comprising over 4% of all 
cancers in males. According to US cancer statistics, it 
was the commonest cancer in males comprising 28% and 
second commonest cause of death from cancer in males 
comprising 11% of all cancer deaths in males. However, 
both the incidence and death rates from prostate cancer 
have declined in the US.(Jemal et al., 2010) Italian 
cancer figures 2006 also demonstrated a decrease in 
mortality from prostate cancer.(AIRT Working Group) 
In India, prostate cancer ranked among the most common 
malignancies in males especially in the largest Indian 
cities like Mumbai, Delhi, Kolkata and Bangalore. Indian 
registries show a statistically significant increase in the 
incidence rate of prostate cancer.(Jain et al., 2014) It has 
a lower fatality rate compared to most other cancers and 
accounts for 5.6% of all cancer deaths in males. Survival 
rates in prostatic cancer are much higher in the developed 
countries.(Brawley, 1997)  In our series, almost 78% 
patients were above 60 years of age. Worldwide, over 75% 
prostate cancers occur above 65 years of age.(Epstein et 
al., 2004) 
The more common malignant tumors encountered 
in our practice have been discussed. It is hoped that this 
study will be an important step towards developing a 
comprehensive cancer registry in Pakistan.
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